This JAMA Clinical Guidelines Synopsis summarizes the 2026 American College of Cardiology (ACC)/American Heart Association (AHA) guideline on management of dyslipidemia.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy | 0 | 11.25 | 18-08-2026 |
| 2 | Cardiovascular Risk Reclassification With the 2026 Dyslipidemia Guideline | 0 | 11.38 | 18-08-2026 |
| 3 | New Dyslipidemia Guidelines Lower the Lipid Treatment Goals and Raise the Bar for Clinical Practice | 0 | 6.02 | 18-08-2026 |
| 4 | Global Burden of Elevated LDL-C | 0 | 10.09 | 29-07-2026 |
| 5 | Patient Information: Cyclosporiasis | 0 | 7.35 | 21-07-2026 |
| 6 | 2026 ACM Conferentie over Reproducibility and Replicability | 0 | 0 | 20-07-2026 |
| 7 | Insight Network Summit | 0 | 5 | 04-06-2026 |
| 8 | 2026 Global Trade and Innovation Policy Alliance Summit | 0 | 10.72 | 11-09-2026 |
| 9 | X 2026 | 0 | 0 | 19-07-2026 |
| 10 | Announcing our 2026 strategy | 0 | 35 | 27-02-2026 |